Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Residual non-specific and disease-specific inflammatory markers in successfully treated young psoriasis patients : a cross-sectional study
Avtorji:ID Merzel Šabović, Eva Klara (Avtor)
ID Kraner Šumenjak, Tadeja (Avtor)
ID Božič Mijovski, Mojca (Avtor)
ID Janić, Miodrag (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,29 MB)
MD5: 32A7D85803E56FF3D441DC48FFD717D0
 
URL URL - Izvorni URL, za dostop obiščite https://link.springer.com/article/10.1007/s12026-024-09584-4
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Psoriasis is a chronic, immune-mediated disease. The systemic inflammation triggered by psoriasis contributes significantly to increased cardiovascular risk. While various treatments completely clear the skin, the associated effects on systemic inflammation are not yet clear. We investigated residual systemic inflammation in successfully treated patients. Circulating disease-specific and non-specific inflammatory markers were measured and compared in 80 psoriasis patients (aged 30–45 years) successfully treated with topical therapy, methotrexate, adalimumab, secukinumab or guselkumab, and in 20 healthy controls. Non-specific inflammatory markers (high-sensitivity C-reactive protein (hs-CRP), complete blood count (CBC) parameters, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume-to-platelet ratio (MPR), and red blood cell distribution width-to-platelet ratio (RPR)) and disease-specific inflammatory markers (interferon-γ (IFN-γ), tumor necrosis factor (TNF), interleukin (IL)-1β, IL-12p70, IL-17, and IL-23) were measured and compared between groups. Disease-specific cytokines (IFN-γ, TNF, IL-1β, IL-12p70, and IL-17, but not IL-23), were significantly elevated in patients compared to controls, while non-specific inflammatory markers showed no differences compared to controls. The residual disease-specific cytokines were similarly elevated in all five treated groups. In addition, they correlated significantly with body mass index (BMI) and waist circumference. Our results suggest that psoriasis patients have elevated residual disease-specific cytokines despite successful treatment, while the non-specific inflammatory markers are similar to those in control subjects. Residual disease-specific inflammatory markers correlated with BMI and waist circumference. A possible beneficial effect of body weight control in psoriasis patients merits further investigation. The study was registered at http://clinicaltrials.gov (identifier: NCT05957120) on July 24, 2023.
Ključne besede:psoriasis, biologic therapy, infammation, cytokines
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:10 str.
Številčenje:Vol. 73, article no. 28
PID:20.500.12556/DiRROS-24519 Novo okno
UDK:616-097
ISSN pri članku:1559-0755
DOI:10.1007/s12026-024-09584-4 Novo okno
COBISS.SI-ID:235767811 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 13. 5. 2025;
Datum objave v DiRROS:03.12.2025
Število ogledov:48
Število prenosov:22
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Immunologic research
Skrajšan naslov:Immunol. res.
Založnik:Humana Press
ISSN:1559-0755
COBISS.SI-ID:513676313 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P3-0308-2019
Naslov:Ateroskleroza in tromboza

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Nazaj